Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report

Basit Öğe Kaydı
dc.contributor.authorUguz, Faruk
dc.contributor.authorSonmez, Erdem Onder
dc.date.accessioned2024-02-23T14:02:59Z
dc.date.available2024-02-23T14:02:59Z
dc.date.issued2013
dc.departmentNEÜen_US
dc.description.abstractNeuroleptic malignant syndrome (NMS) is a rarely observed life-threatening medical condition due mostly to antipsychotic use. Additionally, a few case reports have suggested an association between NMS and the use of selective serotonin reuptake inhibitors (SSRIs) alone or in combination with antipsychotics. This case report presents a female patient developing NMS following the use of a combination of sertraline and paroxetine. (C) 2013 Elsevier Inc. All rights reserved.en_US
dc.identifier.doi10.1016/j.genhosppsych.2012.11.004
dc.identifier.issn0163-8343
dc.identifier.issn1873-7714
dc.identifier.issue3en_US
dc.identifier.pmid23312145en_US
dc.identifier.scopus2-s2.0-84876999247en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1016/j.genhosppsych.2012.11.004
dc.identifier.urihttps://hdl.handle.net/20.500.12452/11927
dc.identifier.volume35en_US
dc.identifier.wosWOS:000318995800023en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofGeneral Hospital Psychiatryen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntidepressantsen_US
dc.subjectNeuroleptic Malignant Syndromeen_US
dc.subjectSertralineen_US
dc.subjectParoxetineen_US
dc.titleNeuroleptic malignant syndrome following combination of sertraline and paroxetine: a case reporten_US
dc.typeEditorial Materialen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu